Scott Caldwell - Acacia Pharma Independent Director

Director

Mr. Scott A. Caldwell serves as an Independent Director of Atacama Pacific Gold Corporationrationration., since October 4, 2011. Mr. Caldwell was President and Chief Executive Officer of Guyana Goldfields Inc. since 2013. Formerly he was President and Chief Executive Officer of Allied Nevada from 2007 to 2013. Mr. Caldwell brings to the Board broad mining experience and public company service through his various executive and board positions since 2011.
Age 58
Tenure 13 years
Phone44 1223 919760
Webhttps://www.acaciapharma.com
Caldwell received a BS Degree in Mining Engineering from the University of Arizona in 1981.

Acacia Pharma Management Efficiency

The company has return on total asset (ROA) of (40.36) % which means that it has lost $40.36 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (155.35) %, meaning that it generated substantial loss on money invested by shareholders. Acacia Pharma's management efficiency ratios could be used to measure how well Acacia Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 28.02 M in total debt with debt to equity ratio (D/E) of 1.08, which is about average as compared to similar companies. Acacia Pharma Group has a current ratio of 3.71, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Acacia Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Acacia Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acacia Pharma Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acacia to invest in growth at high rates of return. When we think about Acacia Pharma's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Carl PradelliFlexShopper
47
Walter McLallenAerCap Holdings NV
50
Harrington BischofOld Republic International
85
Homaid ShemmariAerCap Holdings NV
50
Howard DvorkinFlexShopper
N/A
Brian PosnerArch Capital Group
56
Salem NoaimiAerCap Holdings NV
42
Michael WalshAerCap Holdings NV
53
Dennis MieghemOld Republic International
77
John BunceArch Capital Group
59
Jimmy DewOld Republic International
79
Charles KovaleskiasOld Republic International
N/A
Laurie GoodmanArch Capital Group
62
Homaid ShimmariAerCap Holdings NV
50
James LawrenceAerCap Holdings NV
67
Charles TittertonOld Republic International
76
Eric DoppstadtArch Capital Group
58
James AllenFlexShopper
43
Robert WardenAerCap Holdings NV
47
Charles KovaleskiOld Republic International
72
Scott KingFlexShopper
61
Acacia Pharma Group plc, a hospital pharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, other invasive procedures, or cancer chemotherapy treatments in the United States and internationally. Acacia Pharma Group plc was founded in 2007 and is based in Cambridge, the United Kingdom. Acacia Pharma is traded on OTC Exchange in the United States. Acacia Pharma Group [ACPGF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Acacia Pharma Group Leadership Team

Elected by the shareholders, the Acacia Pharma's board of directors comprises two types of representatives: Acacia Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acacia. The board's role is to monitor Acacia Pharma's management team and ensure that shareholders' interests are well served. Acacia Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acacia Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul Champagne, Independent Director
Thomas Pladsen, CFO and Secretary
Albrecht Schneider, Executive Chairman and Member of Environmental, Health and Safety Committee
Scott Caldwell, Independent Director
Carl Hansen, CEO and President and Director
Marcio Fonseca, Director
Antonio Ortuzar, Director

Acacia Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Acacia Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acacia Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acacia Pharma's short interest history, or implied volatility extrapolated from Acacia Pharma options trading.

Pair Trading with Acacia Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acacia Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acacia Pharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Acacia Pharma Group information on this page should be used as a complementary analysis to other Acacia Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Acacia Pink Sheet

If you are still planning to invest in Acacia Pharma Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acacia Pharma's history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements